Please login to the form below
Wixela Inhub
This page shows the latest Wixela Inhub news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
GSK’s Advair Diskus faces first generic in US
Analysts predict around $250m in sales for Wixela Inhub this year. ... Mylan’s version of the drug is called Wixela Inhub and it has made it to the market ahead of rivals from the likes of Novartis’ Sandoz unit and Hikma/Vectura,
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Account Manager
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Director, Medical Education
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
-
Publications director
-
Competitive salary and bonus scheme
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Manager (PR)
-
Great Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account director
-
Competitive salary and bonus scheme
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Coronavirus outbreak escalation could impact drug supply chain
- Researchers discover new antibiotic using AI
- Genital herpes vaccine candidate heads for human studies
- Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA
- AVENIR GLOBAL appoints global healthcare lead
- Bedrock Group bolsters team with three key appointments
- AXON recognised for ‘excellence in wellbeing’ by Great Place to Work
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC
- Menlo slumps as itching drug fails mid-stage trial
PMHub
Frontera Group
Welcome to Frontera Group, where our agencies immerse you in the world of the patient...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
